Showing results (1-10 of 247) with videos related to
Sort By:
Pageof 25
Diagnostic Microbiology and Infectious Disease|January 9, 2018
Activity of CD101, a long-acting echinocandin, against clinical isolates of Candida aurisElizabeth L Berkow, Shawn R LockhartClinical Microbiology Newsletter|March 17, 2025
Antifungal Susceptibility Testing - The Times They Are a Changin'Shawn R Lockhart, Elizabeth L BerkowThe Journal of Antimicrobial Chemotherapy|August 8, 2018
Activity of novel antifungal compound APX001A against a large collection of Candida aurisElizabeth L Berkow, Shawn R LockhartClinical Microbiology Newsletter|March 17, 2018
Hot topics in antifungal susceptibility testing: A new drug, a bad bug, sweeping caspofungin testing under the rug, and solving the ECV shrugShawn R Lockhart, Elizabeth L BerkowInfection and Drug Resistance|August 18, 2017
Fluconazole resistance in Candida species: a current perspectiveElizabeth L Berkow, Shawn R LockhartClinical Microbiology Reviews|May 1, 2020
Antifungal Susceptibility Testing: Current ApproachesElizabeth L Berkow, Shawn R Lockhart, Luis Ostrosky-ZeichnerThe Journal of Antimicrobial Chemotherapy|January 6, 2018
Changes in the epidemiological landscape of invasive candidiasisFrederic Lamoth, Shawn R Lockhart, Elizabeth L Berkow, et al.Journal of Clinical Microbiology|January 7, 2021
Categorizing Susceptibility of Clinical Isolates of Candida auris to Amphotericin B, Caspofungin, and Fluconazole by Use of the CLSI M44-A2 Disk Diffusion MethodNatalie S Nunnally, Tajah Damm, Shawn R Lockhart, et al.Clinical Microbiology Newsletter|March 6, 2018
Candida auris for the clinical microbiology laboratory: Not your grandfather's Candida speciesShawn R Lockhart, Elizabeth L Berkow, Nancy Chow, et al.Microbiology Spectrum|January 11, 2023
In Vitro Activity of the Novel Antifungal Olorofim against Scedosporium and Lomentospora prolificansOurania Georgacopoulos, Natalie Nunnally, Derek Law, et al.Pageof 25